Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Imbruvica

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Ibrutinib (Imbruvica; Pharmacyclics) is the first Food and Drug Administration–approved inhibitor of Burton’s tyrosine kinase… 
  • figure 1
Review
2016
Review
2016
To the editor: Ibrutinib is an irreversible inhibitor of Bruton tyrosine kinase in the B-cell receptor signaling pathway. In… 
  • table 1
  • figure 1